166 related articles for article (PubMed ID: 28349332)
1. A Nomogram for Predicting Overall Survival of Gastric Cancer Patients with Insufficient Lymph Nodes Examined.
Wang PL; Xiao FT; Gong BC; Liu FN; Xu HM
J Gastrointest Surg; 2017 Jun; 21(6):947-956. PubMed ID: 28349332
[TBL] [Abstract][Full Text] [Related]
2. Application value of nomogram and prognostic factors of gastric cancer patients who underwent D2 radical lymphadenectomy.
Mu GC; Huang Y; Liu ZM; Wu XH; Qin XG; Chen ZB
BMC Gastroenterol; 2019 Nov; 19(1):188. PubMed ID: 31729975
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.
Jiao XG; Deng JY; Zhang RP; Wu LL; Wang L; Liu HG; Hao XS; Liang H
World J Gastroenterol; 2014 Apr; 20(13):3640-8. PubMed ID: 24707149
[TBL] [Abstract][Full Text] [Related]
5. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
6. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
[TBL] [Abstract][Full Text] [Related]
7. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
8. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the tumor-node-metastasis (TNM) classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China.
Deng J; Zhang R; Pan Y; Wang B; Wu L; Jiao X; Bao T; Hao X; Liang H
Surgery; 2014 Jul; 156(1):64-74. PubMed ID: 24929759
[TBL] [Abstract][Full Text] [Related]
10. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.
Chen S; Rao H; Liu J; Geng Q; Guo J; Kong P; Li S; Liu X; Sun X; Zhan Y; Xu D
Oncotarget; 2017 Jul; 8(28):45585-45596. PubMed ID: 28489596
[TBL] [Abstract][Full Text] [Related]
11. A nomogram for predicting individual survival of patients with gastric cancer who underwent radical surgery with extended lymph node dissection.
Song KY; Park YG; Jeon HM; Park CH
Gastric Cancer; 2014 Apr; 17(2):287-93. PubMed ID: 23712439
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer.
Hirabayashi S; Kosugi S; Isobe Y; Nashimoto A; Oda I; Hayashi K; Miyashiro I; Tsujitani S; Kodera Y; Seto Y; Furukawa H; Ono H; Tanabe S; Kaminishi M; Nunobe S; Fukagawa T; Matsuo R; Nagai T; Katai H; Wakai T; Akazawa K
Ann Oncol; 2014 Jun; 25(6):1179-84. PubMed ID: 24669009
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram to individually predict survival of young patients with nonmetastatic gastric cancer: A retrospective cohort study.
Wu C; Wang N; Zhou H; Wang T; Zhao D
Saudi J Gastroenterol; 2019; 25(4):236-244. PubMed ID: 30719999
[TBL] [Abstract][Full Text] [Related]
14. Development and external validation of a nomogram for predicting the conditional probability of survival after D2 lymphadenectomy for gastric cancer: A multicentre study.
Chen QY; Zhong Q; Wang W; Desiderio J; Liu ZY; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Li P; Zheng CH; Zhou ZW; Parisi A; Huang CM
Eur J Surg Oncol; 2019 Oct; 45(10):1934-1942. PubMed ID: 31027946
[TBL] [Abstract][Full Text] [Related]
15. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
17. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.
Kim Y; Spolverato G; Ejaz A; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby D; Worhunsky D; Saunders N; Levine EA; Cho CS; Maithel SK; Pawlik TM
Ann Surg Oncol; 2015; 22(6):1828-35. PubMed ID: 25388061
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer.
Lee SR; Kim HO; Son BH; Shin JH; Yoo CH
World J Surg; 2012 May; 36(5):1096-1101. PubMed ID: 22382768
[TBL] [Abstract][Full Text] [Related]
19. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby DA; Worhunsky D; Saunders N; Cho CS; Levine EA; Maithel SK; Pawlik TM
Ann Surg; 2015 Dec; 262(6):991-8. PubMed ID: 25563867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
